Human IL-2 receptor β mutations associated with defects in immunity and peripheral tolerance

Authors:
  • ZZZinan Zhang
    Zinan Zhang
  • FGFlorian Gothe
    Florian Gothe
  • PPPerrine Pennamen
    Perrine Pennamen
  • JJJohn James
    John James
  • DMDavid MacDonald
    David MacDonald
  • CMCarlos P. Mata
    Carlos P. Mata
  • YMYorgo Modis
    Yorgo Modis
  • MAMeghan Acres
    Meghan Acres
  • WHWolfram Haller
    Wolfram Haller
  • CBClaire Bowen
    Claire Bowen
  • RDRainer Doffinger
    Rainer Doffinger
  • JSJan Sinclair
    Jan Sinclair

Abstract
Interleukin-2, which conveys essential signals for effective immunity and immunological tolerance, operates through a heterotrimeric receptor comprised of α, β and γ chains. Genetic deficiency of the α or γ chain causes debilitating disease. Here we identify human interleukin-2 receptor (IL-2R) β chain (CD122) gene defects as a cause of life-threatening dysregulation of immunity and peripheral tolerance. We report homozygous mutations in the human IL-2Rβ gene from four consanguineous families, comprising either recessive missense mutations in five children or an early stop-gain mutation in two deceased fetuses and a premature neonate. All patients surviving to childhood presented with autoantibodies, hypergammaglobulinemia, bowel inflammation, and dermatological abnormalities, as well as cytomegalovirus disease in most cases. Patient T lymphocytes lacked surface expression of IL-2Rβ and were unable to normally respond to high-dose IL-2 stimulation. By contrast, patient natural killer (NK) cells retained partial IL-2Rβ expression and cytotoxic function. IL-2Rβ loss of function was recapitulated in a recombinant system, in which endoplasmic reticulum sequestration was revealed as the mechanism by which certain missense mutations cause disease. Hematopoietic stem cell transplant resulted in resolution of clinical symptoms in one patient. The hypomorphic nature of this disease highlights the significance of variable IL-2Rβ expression in different lymphocyte subsets as a means of modulating immune function. Insights from these patients can inform the development of IL-2-based therapeutics for immunological diseases and cancer.
All Related Versions

This publication has 26 references indexed in Scilit: